Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.96
-0.34 (-5.40%)
At close: May 15, 2026, 4:00 PM EDT
6.08
+0.12 (2.01%)
After-hours: May 15, 2026, 7:58 PM EDT
Taysha Gene Therapies Employees
Taysha Gene Therapies had 99 employees as of December 31, 2025. The number of employees increased by 26 or 35.62% compared to the previous year.
Employees
99
Change (1Y)
26
Growth (1Y)
35.62%
Revenue / Employee
$75,465
Profits / Employee
-$1,311,879
Market Cap
1.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 26 | 35.62% |
| Dec 31, 2024 | 73 | 21 | 40.38% |
| Dec 31, 2023 | 52 | -13 | -20.00% |
| Dec 31, 2022 | 65 | -113 | -63.48% |
| Dec 31, 2021 | 178 | 140 | 368.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Zymeworks | 264 |
| Viridian Therapeutics | 252 |
| Capricor Therapeutics | 231 |
| uniQure | 221 |
TSHA News
- 9 days ago - Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c) - TheFly
- 9 days ago - Taysha Gene Therapies Earnings Call Transcript: Q1 2026 - Transcripts
- 9 days ago - Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 - GlobeNewsWire
- 18 days ago - Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting - GlobeNewsWire
- 4 weeks ago - Unusually active option classes on open April 16th - TheFly
- 5 weeks ago - Taysha Gene Therapies price target raised to $17 from $14 at Canaccord - TheFly